ARCHIVES

Top Management Shifts At Bristol-Myers Squibb Oncology, R&D Units

This article is from The Cancer Letter archive.

Vol. 21 No. 38 | October 6, 1995

Download PDF Visit The Full Archive

Related Articles

Cancer center directors to develop blueprint for progress that’s “honest,” M.D. Anderson’s John Mendelsohn says.

November 23, 2005

Clinical Cooperative Groups Funding To Decrease 42.5 Mil.

October 11, 1985

Foundation Issues Call For Tobacco Policy Research Proposals

November 27, 1992

Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial

April 27, 2012

RFA For Patient Compliance Study

September 26, 1980

NIH Extramural Office Lists Initiatives For Reinvention

January 13, 1995